Stria Terminalis
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Stria Terminalis</th> </tr> <tr> <td class="label">Location </td> <td>Between amygdala and hypothalamus, around thalamus</td> </tr> <tr> <td class="label">Type </td> <td>Limbic system fiber tract</td> </tr> <tr> <td class="label">Origin </td> <td>Amygdala (central, medial nuclei)</td> </tr> <tr> <td class="label">Termination </td> <td>Hypothalamus, septal nuclei, preoptic area</td> </tr> <tr> <td class="label">Direction </td> <td>Bidirectional</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Neurotransmitter</td> <td>Function</td> </tr> <tr> <td class="label">GABA</td> <td>Main inhibitory transmitter</td> </tr> <tr> <td class="label">Glutamate</td> <td>Excitatory projections</td> </tr> <tr> <td class="label">CRF</td> <td>Stress response modulation</td> </tr> <tr> <td class="label">Oxytocin</td> <td>Social behavior</td> </tr> <tr> <td class="label">Vasopressin</td> <td>Social memory</td> </tr> </table>
Stria Terminalis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Stria Terminalis
Introduction <table class="infobox infobox-cell"> <tr> <th class="infobox-header" colspan="2">Stria Terminalis</th> </tr> <tr> <td class="label">Location </td> <td>Between amygdala and hypothalamus, around thalamus</td> </tr> <tr> <td class="label">Type </td> <td>Limbic system fiber tract</td> </tr> <tr> <td class="label">Origin </td> <td>Amygdala (central, medial nuclei)</td> </tr> <tr> <td class="label">Termination </td> <td>Hypothalamus, septal nuclei, preoptic area</td> </tr> <tr> <td class="label">Direction </td> <td>Bidirectional</td> </tr> <tr> <td class="label">Taxonomy</td> <td>ID</td> </tr> <tr> <td class="label">Neurotransmitter</td> <td>Function</td> </tr> <tr> <td class="label">GABA</td> <td>Main inhibitory transmitter</td> </tr> <tr> <td class="label">Glutamate</td> <td>Excitatory projections</td> </tr> <tr> <td class="label">CRF</td> <td>Stress response modulation</td> </tr> <tr> <td class="label">Oxytocin</td> <td>Social behavior</td> </tr> <tr> <td class="label">Vasopressin</td> <td>Social memory</td> </tr> </table>
Stria Terminalis is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Stria Terminalis (also called the Terminal Stria or Bed Nucleus of the Stria Terminalis - BNST - when enlarged) is a major limbic system fiber tract that connects the amygdala to the hypothalamus and septal nuclei. It plays crucial roles in stress responses, fear conditioning, and autonomic regulation.
Overview The stria terminalis is a bidirectional fiber tract that runs in an arc around the thalamus, from the amygdala to the hypothalamus. The bed nucleus of the stria terminalis (BNST) is the enlarged anterior portion of this tract.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)
Anatomy The stria terminalis contains:
Amygdalofugal fibers : From amygdala to hypothalamus
Hypothalamoamygdalar fibers : Return projections
BNST : Enlarged anterior portion
The BNST has multiple subnuclei:
Oval nucleus (ovBNST)
Dorsal BNST
Ventral BNST
Lateral BNST
Molecular Markers
CRH : Corticotropin-releasing hormone [neurons](/entities/neurons)
Norepinephrine transporter : Dense innervation
GABA : Primary neurotransmitter
Oxytocin receptors : Stress regulation
Normal Function
Stress Response
HPA axis regulation
Anxiety and fear circuits
Autonomic responses
Fear and Anxiety
Conditioned fear responses
Sustained anxiety
Extinction learning
Autonomic Control
Cardiovascular regulation
Neuroendocrine responses
Thermal regulation
Role in Neurodegeneration
Alzheimer's Disease
BNST affected in AD
Stress axis dysregulation
Circadian disturbances
Parkinson's Disease
Autonomic dysfunction
Mood/anxiety symptoms
Non-motor manifestations
Other Disorders
Anxiety disorders : BNST hyperactivation
PTSD : Altered BNST function
Depression : Stress system dysregulation
Transcriptomic Profile Single-nucleus studies reveal:
CRH neurons : Crh+, Crhr1+
GABAergic neurons : Gad1+, Gad2+
Noradrenergic inputs : Th+, Dbh+
Oxytocin neurons : Oxt+
Therapeutic Implications BNST is targeted by:
CRH antagonists : For anxiety/stress
Benzodiazepines : Anxiolytic effects
DBS : For PTSD/anxiety
CRTR modulators : Stress reduction
Research Directions
Circuit manipulation : Optogenetics of BNST
Stress disorders : BNST in PTSD
Imaging : BNST as biomarker
Neurochemical Profile The stria terminalis contains diverse neurochemical populations:
Receptor Distribution
GABA-A receptors: abundant
GABA-B receptors: moderate
CRF receptors: stress-related regions
Oxytocin receptors: social processing areas
Circuitry
Amygdala (primary source)
Central nucleus
Basolateral nucleus
[Hippocampus](/brain-regions/hippocampus) (ventral subiculum)
Hypothalamus (medial preoptic area)
Bed nucleus of the stria terminalis (recurrent)
Outputs from Stria Terminalis
Hypothalamic nuclei
Paraventricular nucleus
Dorsomedial hypothalamus
Limbic [cortex](/brain-regions/cortex)
Brainstem autonomic centers
Midbrain periaqueductal gray
Functional Implications
Stress Response
Modulates HPA axis activity
Integrates stress signals
Affects anxiety behaviors
Social Behavior
Oxytocin signaling
Social recognition
Pair bonding
Autonomic Control
Heart rate regulation
Blood pressure control
Respiratory modulation
Clinical Relevance
Anxiety Disorders
Elevated activity in PTSD
Target for deep brain stimulation
Biomarker potential
Substance Abuse
Role in addiction circuitry
Withdrawal symptoms
Relapse mechanisms
Therapeutic Approaches
Pharmacological modulation
Optogenetic manipulation
Mindfulness-based interventions
Background The study of Stria Terminalis has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References <sup>[1]</sup> Dong HW, et al. Atlas of the forebrain. Brain Res. 2001;900(1):1-32.
<sup>[2]</sup]gt; Walker DL, et al. Role of the bed nucleus of the stria terminalis in anxiety. Biol Psychiatry. 2003;54(12):1365-1377.
<sup>[3]</sup> Crestani CC, et al. Mechanisms in the bed nucleus of the stria terminalis. Neuropharmacology. 2013;63:967-979.
<sup>[4]</sup]gt; Gilpin NW, et al. Bed nucleus of the stria terminalis. Handb Clin Neurol. 2021;180:137-160.
[Amygdala](/brain-regions/amygdala)
[Hypothalamus](/brain-regions/hypothalamus)
Stress Response
Anxiety
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
External Links
[Bed Nucleus of the Stria Terminalis - Wikipedia](https://en.wikipedia.org/wiki/Bed_nucleus_of_the_stria_terminalis)
[Allen Brain Atlas](https://human.brain-map.org/)
See Also
[Neurodegeneration](/wiki/diseases-neurodegeneration) — cell_type_involved_in
Show full description